Valli Mani

Dr. Valli Mani


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2021 in Cureus
Verified
Journal Article
Open access
PDF file
EEEduardo D. Espiridion
Eduardo D. Espiridion
VMValli Mani
Valli Mani
AOAdeolu O Oladunjoye
Adeolu O Oladunjoye
We present a case of neuroleptic malignant syndrome (NMS) in a 46-year-old white female from a state psychiatric hospital who also tested positive for coronavirus-2019 (COVID-19) (severe acute respiratory syndrome coronavirus, SARS-CoV-2) infection after re-introduction of her home antipsychotics medication. She presented with confusion and altered mental status likely secondary to delirium from COVID-19 infection. Clozapine and risperidone were initially held on admission and restarted after continuing agitation on day two. She began to have increased restlessness with rising creatinine kinase (CK) levels, peaking on day seven with sudden fever, hypertension, and tachycardia. The diagnosis of NMS was confirmed, antipsychotic medication was held, and appropriate treatment was administered. The mechanism explaining the occurrence of NMS in COVID-19 patients is still unclear, but COVID-19 infection may be a risk factor for this presentation. The mechanism of SARS-CoV-2 as a risk factor for NMS is still uncertain and needs to be investigated further. However, if their infection status is known, patients should be given neuroleptics with caution and carefully considered for the development of this rare condition.

29 July 2025 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
VMValli Mani
Valli Mani
IBIlan Berlinrut
Ilan Berlinrut
FWFrances Wallach
Frances Wallach
ESEsther Benamu Sultan
Esther Benamu Sultan
MAMersema Abate
Mersema Abate
Enterococcus cecorum is a bacterium typically found in the gastrointestinal tract of chickens, with rare cases reported in humans. We present a case of Enterococcus cecorum bacteremia in a renal transplant recipient with possible source of pet parrots. We also review the literature on E. cecorum infection in humans.

1 January 2021 in IDCases
Verified
Journal Article
Open access
VMValli Mani
Valli Mani
EHEric Hudgins
Eric Hudgins
Balamuthia mandrillaris is a free-living amoeba that may result in a disseminated infection of the central nervous system called granulomatous amoebic encephalitis. We present a case of balamuthiasis in a Hispanic male with poorly controlled type 2 diabetes mellitus (hemoglobin A1C of 12.2 %) who did not have access to healthcare. He initially presented with the non-specific symptoms of blurry vision, headache and imbalance which rapidly progressed to altered mental status over two months. Imaging revealed multiple peripherally enhancing lesions throughout the cerebellum and cortical regions which corresponded to the patient’s deficits. Brain biopsy showed amoebic forms consistent with Balamuthia mandrillaris and later confirmed with cerebrospinal fluid PCR. Our patient was treated with a combination of various antimicrobials, including azithromycin, fluconazole, flucytosine, sulfadiazine, and miltefosine. Unfortunately, his prognosis continued to worsen and he ultimately died after being placed on comfort care.

27 November 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
VMValli Mani
Valli Mani
AZAdam Zimilover
Adam Zimilover
JHJI-CHENG HSIEH
JI-CHENG HSIEH
MGMaham Ghani
Maham Ghani
SKSimon Kashfi
Simon Kashfi
HDHenry Donaghy
Henry Donaghy
Cryptococcosis is a fungal infection that can cause pulmonary, central nervous system, or disseminated disease in immunosuppressed individuals. Although pulmonary cryptococcosis is known to rarely affect immunocompetent patients, there is limited research comparing the incidence and clinical outcomes of cryptococcosis in immunocompetent versus immunocompromised patients. A retrospective analysis was performed on patients with confirmed positive CSF PCR, CSF antigen, or serum cryptococcal antigen tests from 8 hospitals in New York from 2017-2022. Patients were classified as immunocompromised if they had HIV, an organ transplant, active cancer, or were on immunosuppressive medications at the time of diagnosis. Baseline demographic information, comorbidities, and clinical outcomes were recorded. Statistical methods performed include t-test, Chi-square, and Fisher exact test. 37 cases were identified with 9 cases (24%) in immunocompetent patients. There were no significant differences in age (p=0.82), gender (p=0.61), or BMI (p=0.15) amongst immunocompetent vs immunocompromised patients. Immunocompetent patients were more likely to have diabetes compared to immunocompromised patients (44% vs 21%, p = 0.04). Immunocompetent patients presented with meningitis more frequently (78% vs 41%, p = 0.05) with decreased mortality (11% vs 18%, p = 0.04) and no significant differences in rates of fungemia (21% vs 22%, p = 0.28). The majority of immunocompetent patients were treated inpatient and discharged on fluconazole without documented relapsed infection (77%). When assessing patients before and after 3/30/2020, the midpoint of our data timeline and beginning of the COVID pandemic, the proportion of immunocompetent cases increased (12% vs 35%, p = 0.03) while the total number of cases was relatively unchanged. Meningitis was a more common presentation than pulmonary disease in immunocompetent patients. Immunocompetent patients also had better outcomes with decreased mortality. Overall, the number of immunocompetent patients increased over the study period. Additional information about cryptococcosis in immunocompetent patients, as well as the role of diabetes and COVID infection as potential risk factors, warrants further study. All Authors: No reported disclosures